Shares of drug maker Sun Pharmaceuticals falls 4.2% after March quarter earnings at its US unit Taro missed expectations
Shares of drug maker Sun Pharmaceuticals falls 4.2% after March quarter earnings at its US unit Taro missed expectations
Share this Article
Comment on this Article
Recommended
Please to comment